PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Shikonin ameliorates lipoteichoic acid-induced acute lung injury via promotion of neutrophil apoptosis.

Mouse / Endotoxin/LPS

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 33313945 ↗2020Reported benefit

Shikonin ameliorates lipoteichoic acid-induced acute lung injury via promotion of neutrophil apoptosis.

MouseEndotoxin/LPSC57BL/6Male

Model: Lipoteichoic acid-induced acute lung injury

Shikonin significantly attenuated lipoteichoic acid-induced acute lung injury, decreasing pulmonary neutrophil accumulation and TNF-alpha, IL-1 beta and IL-6 expression, and promoted neutrophil apoptosis through increased caspase-3 activation and reduced Mcl-1, with no change in Bcl-2.

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.